• Log In

  • Events | 19 February, 2013 (16:31)

    China: Shifting Into a New Economic Era

    The whole world is watching China’s economy. While the USA and the EU seem to be stuck in an ongoing economic crisis, China’s economic growth has picked up in the past few months. Does this mean the country’s economic miracle will continue, defying the prophets of doom in the West? Jing Ulrich hopes to give us the answer.

    Will the great reinvention of the Chinese development model succeed? Ms. Ulrich is J.P. Morgan’s Managing Director and Chairman of Global Markets, China and a distinguished commentator on the Chinese economy. She will discuss the impact of the leadership change, the transition of China’s economic model towards private consumption and away from exports and infrastructure as well as give us a forecast for the crucial real estate market.

    DATE: Feb 25 (Monday)
    TIME: 10:30am-12pm
    VENUE: Embassy of Denmark, San Li Tun, Dong Wu Jie 1, 中国北京三里屯东五街1号, Tel.: +86 (10) 8532 9900
    ENTRANCE: free to FCCC members, 80 RMB on the door to non-members
    RESERVATION: at fcccadmin@gmail.com
    **Bring passport or photo ID**

    Jing Ulrich is responsible for covering the J.P. Morgan’s  most senior global clients across all asset classes, and for maintaining relationships with executives at the helm of China’s leading enterprises and government entities. Educated at Harvard and Stanford Universities, Ms. Ulrich is one of the most prominent advisors to the world’s largest asset management companies, sovereign wealth funds, and multinational corporations. She also serves as an advisor to Chinese institutions seeking to invest overseas. Her views influence the allocation of trillions of dollars of assets. Ms. Ulrich has received numerous industry accolades for her work as a China watcher. She is ranked by Fortune and Forbes Magazines as one of the Most Powerful Women in the World and Forbes cited her as one of the twenty youngest Global Power Women. Ms. Ulrich also serves as an independent director on the boards of GlaxoSmithKline (GSK), a leading global healthcare company, and Italian luxury goods firm Ermenegildo Zegna.